Brief: Inspire Medical Systems Inc Announces FDA Approval For Apnea Hypopnea Index Indication Expansion And Increased Body Mass Index Labeling
09/06/2023 13:03
June 9 (Reuters) - Inspire Medical Systems Inc INSP.N :
* INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES FDA APPROVAL FOR
APNEA
HYPOPNEA INDEX INDICATION EXPANSION AND INCREASED BODY MASS
INDEX LABELING
* INSPIRE MEDICAL SYSTEMS INC - UPDATE INCLUDES AN INCREASE
ON
UPPER LIMIT OF APNEA HYPOPNEA INDEX (AHI) TO 100 EVENTS PER HOUR
FROM 65
* INSPIRE MEDICAL SYSTEMS INC - UPDATE RAISES BODY MASS
INDEX
WARNING IN LABELING TO 40 FROM 32
Source text for Eikon: ID:nGNX9MrHCk
Further company coverage: INSP.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Inspire Medical Systems
See all newsUS RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Inspire Medical Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Inspire Medical Q2 revenue falls less than expected
Brief: Inspire Medical Systems, Inc. Announces Appointment Of Seasoned Medical Device Executive Michael H. Carrel To Its Board Of Directors